A goal of transplantation immunology is to be able to induce antigen-specific tolerance in transplant recipients. In the present study we describe an in vivo model of antigen-specific transplantation tolerance to skin allografts Using mice congenic at Qal, a ubiquitously expressed class
The cellular immune mechanisms regulating in vivo rejection responses against tissue allografts are becoming better understood. It is now known that rejection responses against skin allografts are initiated by lymphokine-secreting T-helper (Th) cells and are affected by lymphokine-responsive T-killer (Tk) cells (1, 2) . These two T-cell functions either can be mediated by distinct populations of Th and Tk cells or, alternatively, can be mediated by a single subpopulation of dual-function T cells that secrete helper lymphokines and differentiate into cytolytic effector cells (3, 4) .
In the present study we have examined in vivo rejection responses to skin allografts expressing Qal alloantigens. The Qal alloantigens are class I-like glycoproteins that are encoded by genes to the right of the H-2 complex and whose tissue expression is essentially ubiquitous (5, 6) . From the work of Forman and his colleagues (7, 8) (10) . Bandages were removed on day 7, and the grafts were scored daily until rejection (defined as loss of >80%o ofthe grafted tissue) or the endpoint of the experiment.
In Vitro Cytolytic Tk Cell Responses. Spleen cells (2-4 x 106) from either normal B6 female mice or B6 female mice that had been engrafted with skin allografts were cocultured with 3300 R-irradiated (1 R = 0.258 mC/kg) spleen stimulator cells (4 x 106) in 2-ml cultures for 5 days as described (11) and assayed for cytolytic activity on 51Cr-labeled lipopolysaccharide-induced blast cells as target cells in a 4-hr 51Cr-release assay. Percent specific lysis = 100 x [(experimental -spontaneous release)/(maximum -spontaneous release)].
RESULTS
To initiate in vivo rejection responses against Qala disparate tail skin allografts, most B6 mice must recruit Th cells with additional recognition specificities (1) . To verify the ability of the male-specific antigen HY to provide in vivo helper determinants for the initiation of rejection responses against Qala skin allografts, we engrafted normal B6 female mice with two skin grafts: an "indicator" graft expressing only the target Qa1a antigen and an "inducer" graft expressing the target Qa15 antigen and putative HY helper determinants.
We first examined the ability ofinducer grafts placed either prior to or simultaneously with the indicator grafts to initiate rejection of Qa1a disparate indicator grafts. As shown in Fig.  1 , Qala disparate indicator grafts from B6.Tlea female mice, in the absence of any inducer graft expressing additional helper determinants, were not rejected by most B6 female mice ( Fig. 1 A and B) . However, in the simultaneous presence of an inducer graft from B6.Tlaa male mice expressing Qala target antigens and HY helper determinants, B6 female mice rapidly rejected the Qal indicator grafts, as well as the Qala plus HY inducer grafts (Fig. 1C) We next examined the consequences of initial exposure to the Qala target antigen in the absence of helper determinants. B6 female mice were initially engrafted with Qala indicator grafts on day 0 and were subsequently engrafted at a later time with Qala plus HY bearing inducer grafts. As can be seen in Fig. 2 , animals initially engrafted with Qala grafts alone failed to reject their Qala grafts and were unable to reject them even after rejecting a subsequently placed inducer graft expressing Qala and HY determinants ( Fig. 2A) . Thus, initial exposure to the Qala alloantigen in the absence of helper determinants interfered with the anticipated ability of immunogenic inducer grafts to induce rejection of the Qala indicator grafts. Two possible explanations for this observation were that (i) the initial Qala indicator grafts, because of their long-term retention by B6 host mice, were no longer susceptible to rejection by Qala-specific effector cells for some reason or (ii) initial exposure to Qala alloantigen in the absence of help induced Qala specific nonresponsiveness.
To differentiate between these two mechanisms we performed the following two experiments. First, it can be seen that placement of an inducer graft did not trigger rejection of a previously placed Qala indicator graft and that fresh Qala indicator grafts placed on these mice 62 days after the inducer grafts were also not rejected (Fig. 2B) . Second, on animals that had retained a Qala indicator graft for 60 days, we simultaneously placed a Qala plus HY inducer graft and a fresh second Qala indicator graft (Fig. 2C) . Neither ofthe two Qala indicator grafts was rejected, even though these animals did reject their Qala plus HY inducer grafts (Fig. 2C) . It should be noted that these mice were similar to the mice in Fig. 1C in that they were simultaneously engrafted with a Qala indicator graft and a Qala plus HY inducer graft, but they differed in whether they had initially been exposed to Qala-expressing skin grafts in the absence of additional helper determinants (compare Figs. 1C and 2C) . Thus, the failure of the original Qala indicator grafts to be rejected was not due simply to graft adaptation. Rather, initial exposure to Qala disparate grafts in the absence of additional helper determinants leads to Qalamspecific transplantation tolerance. This nonresponsive state is antigen-specific in that animals that were unable to reject Qala disparate indicator grafts did, nevertheless, reject their HY-bearing inducer grafts (Fig. 2) .
We next examined the ability of spleen T cells from Qalakrejector and Qala-tolerant animals to generate in vitro Tk cell responses (Fig. 3) . Tk cell responses were generated from three different populations of B6 female mice: (i) normal mice that had not been engrafted with any skin, (ii) Qalarejector mice that had been engrafted with Qala plus HY inducer skin grafts and Qala indicator skin grafts, and (iii) Qala-tolerant mice that had been first engrafted with Qala indicator grafts and then subsequently engrafted with Qala plus HY inducer skin grafts. The immune competence of all three responder populations was confirmed by their comparable responses against third party H-2d alloantigens (Fig. 3  D and H) . Because anti-HY and anti-Qala Tk cell responses require previous in vivo priming, only the two skin-engrafted responder B6 T-cell populations would be expected to generate either anti-HY or anti-Qala Tk cells. Indeed, in response to B6.Tlaa stimulator cells expressing Qala plus HY alloantigens, T cells from rejector and tolerant mice generated anti-HY Tk cells (Fig. 3 B and F) . However, rejector mice also generated anti-Qala Tk cells, whereas tolerant mice did not (Fig. 3 C and G) (Fig. 3) , the generation of anti-HY Tk cells in these cultures provided direct evidence cultures. Rather, these experiments demonstrate that initial in vivo exposure of T cells to Qala alloantigen in the absence of T-cell help specifically interferes with the ability of antiQala Tk cells to be subsequently primed, either because anti-Qala Tk cell precursors had been clonally inactivated by their initial encounter with antigen or because anti-Qala T-suppressor cells were generated. The latter possibility, however, is not supported by in vitro cell mixing experiments (Table 1) , although such experiments cannot definitively rule out a possible role for anti-Qala T-suppressor cells.
DISCUSSION
The present study has assessed the possibility that initial exposure to alloantigen in the absence of T-cell help might
Immunology: Rees et al. Rejector animals were engrafted simultaneously on day 0 with B6.Tlaa female indicator skin grafts and B6.Tlaa male inducer skin grafts, which were both rejected on day 15. Tolerant animals were first engrafted on day -60 with B6.Tlaa female skin grafts (that were not rejected) and were then engrafted on day 0 with B6.Tlaa female indicator grafts (that were not rejected) and B6.Tlaa male inducer grafts (that were rejected on day 20). The in vitro assay was performed on day 100.
*Responder spleen cells from rejector animals (Rej) (2 x 106), from tolerant animals (Tol) (2 x 106), or from rejector and tolerant animals (Rej + Tol) (2 x 106 plus 2 x 106) were cocultured for 5 days with 3300 R-irradiated stimulator cells.
tEffector/target ratio. Target cells were 51Cr-labeled lipopolysaccharide-induced spleen blast cells.
Lysis of syngeneic B6 female target cells was <1%.
induce long-lasting transplantation tolerance. The Qala alloantigen seemed to be the ideal transplantation antigen with which to initially approach this question because B6 (Qaib) mice are genetically deficient in Qala-specific Th cells yet possess Qala-specific Tk cells that are able to lyse Qala_ bearing target cells and able to reject Qalakbearing skin allografts (1, 7, 8 Alternatively, it has been proposed that antigen-specific T-suppressor cells are generated upon exposure to antigen under conditions in which T-cell help is either absent or limiting (13 (16, 17) .
Whether the inactivation of Tk cell precursors occurs by clonal inactivation or by clonal suppression, the results of the present study indicate that transplantation tolerance to histocompatibility antigens can be induced by exposing naive Tk cells in recipient animals to alloantigens of the graft under conditions in which T-cell help is not generated. Since CD4+ and CD8+ Th cells are potentially activated by allogeneic tissue allografts (1, 18) , induction of transplantation tolerance would presumably require that neither Th cell population be activated. Indeed, we think it is the failure to activate either Th cell population and the subsequent inactivation of antigen-specific Tk cells that is the basis for recent reports of tolerance induction by injection of alloantigen-bearing cells (19) . Similarly, it is likely the removal of cells able to activate Th cells that is responsible for the long-term retention of in vitro precultured allografts and for their ability to induce transplantation tolerance (20, 21) . Future experiments are necessary to examine the applicability ofthese concepts to in vivo rejection responses against other transplantation antigens. 
